3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting scientific focus due to limited evidence suggesting unique pharmacological properties. Current analyses demonstrate that 3-HPC may exhibit independent responses on the nervous system, possibly playing a role to some of the unexpected symptoms related with PCP